Hyperinsulinaemic hypoglycaemia in small for dates babies. 1990

J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
Department of Child Health, Institute of Child Health, London.

Blood glucose concentrations were measured prospectively in 27 small for dates infants in the first 48 hours after birth: 10 infants became hypoglycaemic. Of these, five had inappropriately raised plasma insulin concentrations. Plasma free fatty acids were lower and carbohydrate intake higher in these five infants, further supporting the diagnosis of hyperinsulinism. The hypoglycaemia recurred in four of the five hyperinsulinaemic infants, but in none of those who were not hyperinsulinaemic. Hyperinsulinism is common in small for dates babies. It is important to recognise this because hypoglycaemia is likely to recur and appropriate treatment is needed to prevent long term sequelae.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007236 Infant, Small for Gestational Age An infant having a birth weight lower than expected for its gestational age.
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D004040 Dietary Carbohydrates Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277) Carbohydrates, Dietary,Carbohydrate, Dietary,Dietary Carbohydrate
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous

Related Publications

J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
June 1991, Archives of disease in childhood,
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
August 1968, Lancet (London, England),
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
February 1981, Early human development,
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
September 1979, British journal of obstetrics and gynaecology,
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
June 1969, Archives of disease in childhood,
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
June 2009, Archives of disease in childhood,
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
March 2014, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
July 1981, Early human development,
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
January 1970, Lancet (London, England),
J E Collins, and J V Leonard, and D Teale, and V Marks, and D M Williams, and C R Kennedy, and M A Hall
February 1973, Nutrition reviews,
Copied contents to your clipboard!